CD294 (CRTH2) Antibody PE 12-2949-42 from Thermo Fisher Scientific | Biocompare.com

Supplier Images

Flow

Staining of normal human peripheral blood cells with Anti-Human CD123 FITC (Product # 11-1239-42) and Rat IgG2a K Isotype Control PE (Product # 12-4321-80) (left) or Anti-Human CD294 (CRTH2) PE (right). Cells in the lymphocyte gate were used for analysis.
Flow

Staining of normal human peripheral blood cells with Anti-Human CD123 FITC (Product # 11-1239-42) and Rat IgG2a K Isotype Control PE (Product # 12-4321-80) (left) or Anti-Human CD294 (CRTH2) PE (right). Cells in the lymphocyte gate were used for analysis.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
CD294 (CRTH2) Antibody PE

Thermo Fisher Scientific's CD294 (CRTH2) Antibody PE is a Rat monoclonal antibody. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD294 (CRTH2) Antibody PE
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog Number12-2949-42
Quantity100 Tests
ApplicationsFlow Cytometry
Concentration5 µL/Test
Conjugate/TagPE
FormatPBS with 0.2% BSA and 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetCD294 (CRTH2)
IsotypeIgG2a kappa
CloneBM16
HostRat
NCBI Full Gene Nameprostaglandin D2 receptor 2
NCBI Gene AliasesCD294, CRTH2, DL1R, DP2, GPR44
ClonalityMonoclonal
PurityAffinity chromatography
Storage Temperature4° C, store in dark, DO NOT FREEZE!
Antibody TypePrimary
Storage4° C, store in dark, DO NOT FREEZE!

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19Science immunologyAugust 19, 2021Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, Zhang P, Meertens L, Bolze A, Materna M, et al.

(2) Expansion of Group 2 Innate Lymphoid Cells in Patients with End-Stage Renal Disease and Their Clinical SignificanceJournal of immunology (Baltimore, Md. : 1950)July 1, 2020Liu GY, Deng XH, Li X, Cao YJ, Xing YF, Zhou P, Lei AH, Yang Q, Deng K, Zhang H, et al.

(3) Effects of myeloid and plasmacytoid dendritic cells on ILC2s in patients with allergic rhinitisThe Journal of allergy and clinical immunologyMarch 1, 2020Peng YQ, Qin ZL, Fang SB, Xu ZB, Zhang HY, Chen D, Liu Z, Bellanti JA, Zheng SG, Fu QL.

Be the First to Write a Review!